LaFleur & Godfrey LLC Acquires 29,416 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• LaFleur & Godfrey LLC increased its Intuitive Surgical stake by 3,785.8% in the third quarter, acquiring 29,416 additional shares and bringing its holdings to 30,193 shares valued at approximately $12.3 million.
• Intuitive Surgical reported strong quarterly results, with revenue up 21.7% year over year to $3.05 billion and EPS of $3.00, beating analyst estimates. Analysts maintain a broadly positive outlook, with a consensus “Moderate Buy” rating and an average price target of $493.54.
• The stock remains richly valued at a P/E ratio of 53.71, while margin concerns and insider selling—including roughly $16.8 million in sales over the past 90 days—could weigh on investor sentiment.

LaFleur & Godfrey LLC boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3,785.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 30,193 shares of the medical equipment provider's stock after acquiring an additional 29,416 shares during the quarter. Intuitive Surgical accounts for approximately 1.5% of LaFleur & Godfrey LLC's investment portfolio, making the stock its 21st biggest holding. LaFleur & Godfrey LLC's holdings in Intuitive Surgical were worth $12,277,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. Beaumont Financial Advisors LLC increased its holdings in Intuitive Surgical by 3.8% during the 3rd quarter. Beaumont Financial Advisors LLC now owns 627 shares of the medical equipment provider's stock worth $255,000 after purchasing an additional 23 shares in the last quarter. W.G. Shaheen & Associates DBA Whitney & Co lifted its holdings in shares of Intuitive Surgical by 1.0% in the first quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider's stock valued at $1,172,000 after purchasing an additional 25 shares in the last quarter. Blue Fin Capital Inc. lifted its holdings in shares of Intuitive Surgical by 0.5% in the first quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider's stock valued at $2,210,000 after purchasing an additional 25 shares in the last quarter. Red Spruce Capital LLC lifted its holdings in shares of Intuitive Surgical by 4.1% in the second quarter. Red Spruce Capital LLC now owns 640 shares of the medical equipment provider's stock valued at $255,000 after purchasing an additional 25 shares in the last quarter. Finally, Worthington Financial Partners LLC boosted its position in shares of Intuitive Surgical by 1.3% during the third quarter. Worthington Financial Partners LLC now owns 1,885 shares of the medical equipment provider's stock valued at $767,000 after buying an additional 25 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Analyst Ratings Changes

Several brokerages recently issued reports on ISRG. JPMorgan Chase & Co. upped their price target on Intuitive Surgical from $450.00 to $475.00 and gave the stock an "overweight" rating in a report on Wednesday, October 21st. Evercore set a $430.00 price objective on Intuitive Surgical in a research note on Monday, July 6th. Wall Street Zen cut Intuitive Surgical from a "buy" rating to a "hold" rating in a research note on Sunday, September 20th. Citigroup cut their price objective on shares of Intuitive Surgical from $590.00 to $500.00 and set a "buy" rating on the stock in a report on Friday, July 17th. Finally, Royal Bank Of Canada reduced their target price on shares of Intuitive Surgical from $575.00 to $550.00 and set an "outperform" rating for the company in a research note on Wednesday, October 21st. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average price target of $493.54.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Wall Street remains broadly bullish on ISRG. The consensus rating is “Moderate Buy,” with an average price target of $493.54, while Zacks recently upgraded the stock to “Strong Buy.” Raymond James and BTIG also reiterated positive ratings. Wall Street Views on Intuitive Surgical
• Positive Sentiment: Intuitive Surgical’s latest quarter showed solid demand: revenue rose 21.7% year over year to $3.05 billion, exceeding estimates, while earnings of $3.00 per share beat the $2.65 consensus. This supports the long-term growth case for its da Vinci robotic-surgery business. Intuitive Surgical Earnings and Valuation
• Neutral Sentiment: Recent performance has been mixed: the stock has rebounded over the past one to three months, but remains below its prior-year level. Investors are assessing whether continued procedure growth and higher estimates can justify ISRG’s premium valuation.
• Negative Sentiment: Several insiders reported stock sales, including EVP Mark Brosius, SVP Patricia Wadors, former CEO Gary Guthart and insider Fredrik Widman. Brosius sold shares in two transactions, while Guthart’s reported sale was approximately $9.1 million. The trades were made under pre-arranged Rule 10b5-1 plans, reducing their signaling value, but the volume of selling may weigh on sentiment. Gary Guthart Insider Sale
• Negative Sentiment: Despite the earnings beat, lower net income and earnings-per-share comparisons have highlighted margin pressure. With ISRG trading at a high earnings multiple, investors may be particularly sensitive to any slowdown in profitability or procedure growth. Why Intuitive Surgical’s Strong Quarter Spooked Investors

Intuitive Surgical Stock Down 0.4%

Shares of NASDAQ ISRG opened at $444.18 on Thursday. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88. The stock's 50 day moving average price is $399.37 and its 200-day moving average price is $435.44. The company has a market capitalization of $153.97 billion, a PE ratio of 53.71, a PEG ratio of 3.12 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.35. The company had revenue of $3.05 billion during the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. Intuitive Surgical's quarterly revenue was up 21.7% on a year-over-year basis. During the same period in the prior year, the company posted $2.40 earnings per share. As a group, research analysts expect that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Craig H. Barratt sold 1,150 shares of the firm's stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total transaction of $510,370.00. Following the completion of the sale, the director directly owned 1,150 shares of the company's stock, valued at $510,370. This trade represents a 50.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia L. Wadors sold 1,078 shares of the firm's stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $443.80, for a total value of $478,416.40. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 38,806 shares of company stock valued at $16,824,795. 0.60% of the stock is currently owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company's primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.